Cuptimize Announces 510(k) FDA Clearance of its New Proprietary Software Designed to Identify and Treat Spinopelvic Motion Abnormalities in Total Hip Replacement
Cuptimize Announces 510(k) FDA Clearance of its New Proprietary Software Designed to Identify and Treat Spinopelvic Motion Abnormalities in Total Hip Replacement Share Article BELLEAIR BLUFFS, Fla. (PRWEB) March 09, 2021 Cuptimize Inc., a medical device software company, focused on spinopelvic motion abnormalities, announced today that it has received FDA clearance for their latest software. The system provides a preoperative and intraoperative solution that relies exclusively on x-ray and requires no CT scan for the preoperativ...
Source: prweb.com